Flindr Therapeutics
Flindr Therapeutics is a precision oncology treatments developer founded in 2020.
1
Funding Rounds
$21.0m
Money raised
Funding series
Funding Series Analysis
The company Flindr Therapeutics has raised a total of $21m in funding over 1 rounds.
Key Insights:
- Flindr Therapeutics April 2024 Series A Funding Round: $21m
Flindr Therapeutics April 2024 Series A Funding Round
$21m
Industries
Flindr Therapeutics is active in the following industries: